Stocks Comparison
Incyte vs OmniAb: revenue, profit, margins and growth compared
Incyte brought in $5.1B of revenue in fiscal 2025, OmniAb $18.7M in fiscal 2025. Revenue changed by +21.2% at Incyte and -29.3% at OmniAb on the year before, so Incyte grew faster. Incyte kept 25.0% of its revenue as net profit, OmniAb -347.0%.
Side by side, latest fiscal year
| INCY | OABI | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $5.1B | $18.7M |
| Revenue growth | +21.2% | -29.3% |
| Net income | $1.3B | -$64.8M |
| Net margin | 25.0% | -347.0% |
| Free cash flow | n/a | -$37M |
| Free cash flow margin | n/a | -198.3% |
| Earnings per share (diluted) | $6.41 | -$0.57 |
| Cash | $3.1B | $25.5M |
| Debt | n/a | n/a |
| Price to earnings | 19.3 | n/a |
| Market value | $25.1B | $670.2M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #60 of 523 · Health care | #413 of 523 · Health care |
Over the years
INCY $5.1BOABI $18.7M
INCY $1.3BOABI -$64.8M
INCY 25.0%OABI -347.0%
INCY +21.2%OABI -29.3%
INCY $892.1MOABI -$37M
Questions about Incyte and OmniAb
Which is bigger by revenue, Incyte or OmniAb?
Incyte is bigger by revenue: $5.1B in fiscal 2025, against $18.7M for OmniAb in fiscal 2025.
Which keeps more of its revenue as profit, Incyte or OmniAb?
Incyte had a net margin of 25.0% in fiscal 2025; OmniAb had -347.0% in fiscal 2025.
Which grew revenue faster, Incyte or OmniAb?
In their latest fiscal years revenue changed by +21.2% at Incyte and -29.3% at OmniAb.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.